Patents by Inventor Adam Lowe

Adam Lowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
    Patent number: 5773450
    Abstract: The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula ##STR1## wherein Q, X.sup.1, x.sup.2 and X.sup.3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: June 30, 1998
    Assignee: Pfizer Inc.
    Inventors: John Adams Lowe, III, Terry Jay Rosen
  • Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
    Patent number: 5744480
    Abstract: The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula ##STR1## wherein Q, X.sup.1, X.sup.2 and X.sup.3 are as defined below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: April 28, 1998
    Assignee: Pfizer Inc.
    Inventors: John Adams Lowe, III, Terry Jay Rosen
  • Quinuclidine derivatives
    Patent number: 5698568
    Abstract: Quinuclidine derivatives of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein m, P, Z, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined below. The compounds are substance P antagonists and, therefore, are useful in treating gastrointestinal disorders, central nervous system disorders, inflammatory diseases, pain and migraine.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: December 16, 1997
    Assignee: Pfizer Inc.
    Inventor: John Adams Lowe, III
  • Quinuclidine derivatives
    Patent number: 5641786
    Abstract: Quinuclidine derivatives of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein m, P, Z, Y, R.sup.1, R.sup.2 and R.sup.3 are as defined below. The compounds are substance P antagonist and, therefore, are useful in treating gastrointestinal disorders, central nervous system disorders, inflammatory diseases, pain and migraine.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: June 24, 1997
    Inventor: John Adams Lowe, III